CEM(002980)

Search documents
【A股收评】三大指数集体走强,军工、黄金卷土重来!
Sou Hu Cai Jing· 2025-08-04 08:01
两市超3700只个股上涨,沪深两市今日成交额约1.50万亿元。 今日,军工板块表现出众。 其中,北方长龙(301357.SZ)涨20%,建设工业(002265.SZ)涨10%,中国海防(600764.SH)、中无人机(688297.SH)、北方导航(600435.SH)均上 涨。 8月4日,三大指数走强。 截至收盘,沪指涨0.66%,深成指涨0.46%,创业板涨0.5%,科创50指数涨1.22%。 中信建投表示,军工板块基本面已经开始加速回暖,2025年上半年各类催化剂特别是订单公告有望持续兑现,业绩拐点已经出现,军工板块具有持续投资价 值。同时,商业航天、低空经济等新域新质方向下半年可能受商业火箭发射等事件影响产业加速发展,并且上半年涨幅相对较低,建议关注相关投资机会。 随着国际金价走强,黄金板块迎来反弹。 其中,赤峰黄金(600988.SH)、山东黄金(600547.SH)、西部黄金(601069.SH)等概念股大涨。 消息面上,美国劳工部统计局最新公布的数据显示,美国7月非农新增就业岗位7.3万个,远低于市场预期的11万个,同时5月、6月的新增就业岗位总数被大 幅下调。受此影响,降息预期升温,国际金价走 ...
华盛昌实控人方近2个月减持370万股 套现7340万元
Zhong Guo Jing Ji Wang· 2025-08-01 08:24
华航企业于2025年6月16日至2025年7月30日期间以集中竞价交易方式减持华盛昌股份853,261股,减持 均价20.80元/股,减持比例(剔除回购专户)0.45%;于2025年6月9日至2025年6月23日期以大宗交易方式 减持华盛昌股份825,746股,减持均价18.66元/股,减持比例(剔除回购专户)0.44%。 经计算,华聚企业于2025年6月10日至2025年7月30日期间减持华盛昌金额为40,245,134.28万元;华航企 业于2025年6月9日至2025年7月30日期间华盛昌金额为33,156,249.16万元。华聚企业、华航企业于上述 期间合计减持华盛昌股份3,703,465股,减持金额为73,401,383.44万元。 本次减持计划披露前,袁剑敏、华聚企业、华航企业合计持股113,910,020股,占华盛昌剔除回购专用账 户股份数量后总股本(188,663,160股)的60.38%;本次减持计划完成后,袁剑敏、华聚企业、华航企业合 计持股110,206,555股,占华盛昌剔除回购专用账户股份数量后总股本(188,663,160股)的58.41%。 华盛昌的控股股东、实际控制人为袁剑敏, ...
深圳市华盛昌科技实业股份有限公司 关于股东减持计划实施完毕的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-07-31 23:27
登录新浪财经APP 搜索【信披】查看更多考评等级 东台华聚企业管理合伙企业(有限合伙)、东台华航企业管理咨询合伙企业(有限合伙)保证向本公司 提供的信息内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 深圳市华盛昌科技实业股份有限公司(以下简称"公司"、"本公司")于2025年4月29日披露了《关于股 东减持股份计划的预披露公告》,公司股东东台华聚企业管理合伙企业(有限合伙)(以下简称"华聚 企业")、东台华航企业管理咨询合伙企业(有限合伙)(以下简称"华航企业")计划以集中竞价、大 宗交易方式减持公司部分股份。具体内容详见公司在《中国证券报》、《证券时报》和巨潮资讯网 (http://www.cninfo.com.cn)披露的公告。 近日,公司收到华聚企业、华航企业出具的《关于股份减持计划实施完毕的告知函》,截至本公告披露 日,华聚企业、华航企业本次减持计划已实施完毕,现将有关情况公告如下: 一、股东减持情况 1、股东减持股份情况 ■ 注:股东华聚企业和华航企业是公司控股股东、实际控制人袁剑敏先生的一致行动人。 减持股份来源:首次 ...
华盛昌(002980) - 关于股东减持计划实施完毕的公告
2025-07-31 12:18
证券代码:002980 证券简称:华盛昌 公告编号:2025-029 深圳市华盛昌科技实业股份有限公司 关于股东减持计划实施完毕的公告 东台华聚企业管理合伙企业(有限合伙)、东台华航企业管理咨询合伙企 业(有限合伙)保证向本公司提供的信息内容真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 深圳市华盛昌科技实业股份有限公司(以下简称"公司"、"本公司")于 2025 年 4 月 29 日披露了《关于股东减持股份计划的预披露公告》,公司股东东 台华聚企业管理合伙企业(有限合伙)(以下简称"华聚企业")、东台华航企 业管理咨询合伙企业(有限合伙)(以下简称"华航企业")计划以集中竞价、 大宗交易方式减持公司部分股份。具体内容详见公司在《中国证券报》、《证券 时报》和巨潮资讯网(http://www.cninfo.com.cn)披露的公告。 近日,公司收到华聚企业、华航企业出具的《关于股份减持计划实施完毕的 告知函》,截至本公告披露日,华聚企业、华航企业本次减持计划已实施完毕, 现将有关情况公告如下: 一、股东减持情况 注:1、本次减持计 ...
华盛昌(002980):动态点评:进军人工智能眼镜领域,拓展多元AI产品矩阵
East Money Securities· 2025-07-31 11:46
Investment Rating - The report assigns an "Accumulate" rating for the company, indicating a positive outlook for its stock performance in the near term [8]. Core Insights - The company is entering the artificial intelligence (AI) glasses market through a joint venture, which is expected to enhance its strategic positioning in the AI sector and create a new ecosystem for professional testing and measurement instruments [1]. - The government has incorporated "AI+" into its national strategy, which is anticipated to drive growth in the smart instruments and equipment industry, benefiting companies like the one under review [7]. - The company has been actively expanding its AI product matrix, focusing on sectors such as "AI+Electricity" and "AI+Healthcare," which are expected to enhance its product offerings and market competitiveness [7]. Financial Projections - The company is projected to achieve a net profit of 180.32 million yuan in 2025, with a corresponding price-to-earnings (P/E) ratio of 22.2X based on the closing price as of July 30, 2025 [8]. - Revenue is expected to grow from 807.50 million yuan in 2024 to 1,411.12 million yuan by 2027, reflecting a compound annual growth rate (CAGR) of approximately 20% [9]. - The net profit attributable to the parent company is forecasted to increase from 138.42 million yuan in 2024 to 288.52 million yuan in 2027, indicating a strong growth trajectory [9].
华盛昌袁剑敏:在仪器仪表赛道推陈出新
Shang Hai Zheng Quan Bao· 2025-07-24 18:58
Core Viewpoint - The company focuses on addressing industry pain points through innovative products, particularly in the photovoltaic sector, leveraging AI technology and expanding its global presence [5][7][11]. Group 1: Industry Pain Points and Innovations - The latest product from the company is an AI smart fault arc detection device aimed at addressing the issue of DC arc fire accidents in the photovoltaic industry [5]. - The company has developed over 1,000 digital detection products across more than 30 fields, showcasing its strong market insight and innovation capabilities [6]. - The introduction of AI smart arc detection solutions, including various models, allows for early warning of arc signals, enhancing safety in complex scenarios [7]. Group 2: AI Integration and Future Developments - The company is actively expanding its AI product matrix, including the establishment of a subsidiary focused on AI glasses, which are expected to revolutionize the detection field [8]. - The AI-7760 series power quality analyzer, equipped with a large model, enhances measurement efficiency and accuracy by providing industry-standard answers to user queries [9]. - Future plans include the development of high-end medical analysis instruments and the integration of AI technology to improve existing product performance [10]. Group 3: Global Expansion and Brand Development - The company aims to transition from OEM manufacturing to establishing its own brands, emphasizing the importance of technological innovation and product competitiveness in international markets [11]. - A new manufacturing base in Vietnam is part of the company's strategy to enhance supply chain resilience and support local enterprises through smart production lines [12]. - The strategic shift towards "localization + globalization" reflects the company's commitment to strengthening its market position and risk management capabilities [12].
迈出AI眼镜第一步 华盛昌锚定新一代专业测量应用新生态
Zheng Quan Shi Bao Wang· 2025-07-13 14:19
Core Viewpoint - The company Huashengchang is entering the AI glasses market through a strategic partnership, aiming to leverage its expertise in measurement instruments to develop industrial-grade AI glasses tailored to specific user needs [1][2][3]. Group 1: Strategic Initiatives - Huashengchang's subsidiary, Deep Sensing, is collaborating with Huawou and Huajing to establish Shenzhen Deepjing Intelligent Technology Co., focusing on AI glasses [1]. - The partnership structure is designed to incentivize internal employees and attract external talent, enhancing innovation and operational efficiency [2]. - The company aims to accelerate its strategic layout in AI glasses due to the maturity of the supply chain, with major players like Baidu and Xiaomi driving rapid development in components and solutions [2]. Group 2: Product Development Focus - Unlike consumer-grade AI glasses, Huashengchang is focusing on developing industrial-grade AI glasses that meet specific professional needs, such as remote diagnostics and measurement [3][4]. - The company recognizes the importance of customizing products based on downstream application scenarios, which presents a significant opportunity in the industrial sector [4]. - Huashengchang's existing expertise in measurement tools positions it well to capture industrial-grade AI glasses market share by leveraging its understanding of client needs [4]. Group 3: Future Vision and Ecosystem - The company envisions creating a next-generation measurement ecosystem, with AI glasses as a foundational element, integrating various wearable devices and measurement instruments [5][6]. - Huashengchang plans to expand its product matrix by developing new professional instruments and medical testing products, while deepening the integration of AI technology [7]. - The company's long-term vision includes re-engineering all its products using AI technology, indicating a commitment to innovation and adaptation in the evolving market landscape [8].
破局光伏运维痛点 华盛昌发布DT-1500PV引领行业智能升级
Zhong Guo Chan Ye Jing Ji Xin Xi Wang· 2025-07-09 06:38
Core Insights - The photovoltaic industry is entering a new phase of healthy and sustainable development, driven by government efforts to regulate chaotic competition and promote product quality [1] - The launch of the DT-1500PV multifunctional photovoltaic I-V curve tester by Huashengchang targets the critical market of efficient and precise testing equipment essential for photovoltaic power station construction and operation [1][2] Industry Overview - The Chinese government has emphasized the need to address "involution" competition in the photovoltaic sector, with multiple high-level meetings focusing on the regulation of low-price competition and the orderly exit of outdated production capacity [1] - The global and national photovoltaic installation forecasts for 2024 are expected to reach 507 GW and 260 GW respectively, with a compound annual growth rate (CAGR) of 40.53% and 52.40% from 2020 to 2024, indicating strong market demand [5] Product Features - The DT-1500PV tester features a high-definition color screen, real-time I-V curve display, online data reading, and the ability to conduct continuous testing with a single connection, making it suitable for complex scenarios [2][3] - It integrates multiple key functions such as visual inspection, grounding resistance testing, and automatic testing, addressing pain points in photovoltaic operation and maintenance [3] Competitive Advantage - The DT-1500PV surpasses international brands like Fluke by measuring voltages up to 1500V, catering to the needs of larger photovoltaic power stations [4] - Huashengchang's ability to control costs and provide localized services positions it favorably against foreign competitors, facilitating a shift from reliance on imports to domestic production in the photovoltaic testing equipment market [4] Market Trends - The demand for photovoltaic testing equipment is expected to surge due to the dual drivers of anti-involution policies and carbon neutrality goals, with the operation and maintenance market poised to benefit from the increasing installation of photovoltaic systems [5][6] - Emerging applications such as data centers and green hydrogen plants are becoming new growth areas for photovoltaic utilization, further expanding the market for testing equipment [5][6]
华盛昌发布多功能光伏测试仪 加速转型综合能源技术服务商
Zheng Quan Shi Bao Wang· 2025-07-08 12:55
Group 1 - The core viewpoint of the articles is the launch of the DT-1500PV multifunctional photovoltaic I-V curve tester by Huashengchang, which enhances the company's testing technology and competitiveness in the photovoltaic industry [1][2] - The DT-1500PV features real-time display of I-V curves on a high-definition color screen, supports online data reading, and allows for continuous testing with a single connection, making it suitable for various testing scenarios [1] - The product aims to support the "dual carbon" goals and promote sustainable development in the photovoltaic industry, transitioning the company from a single product provider to a comprehensive energy technology service provider [1] Group 2 - Huashengchang specializes in the research, development, production, and sales of testing and measurement instruments, focusing on high precision and specialized needs for specific industries [2] - The company has developed a series of professional instruments and testing devices for the photovoltaic sector, including tools for solar component installation, inverter maintenance, and energy storage system regulation [2] - The product line includes energy quality clamp meters and specialized solar irradiance meters, which help improve the overall performance and lifespan of photovoltaic systems while maximizing energy generation efficiency [2]
7月4日体外诊断上涨0.24%,板块个股热景生物、塞力医疗涨幅居前
Sou Hu Cai Jing· 2025-07-04 09:36
Core Viewpoint - The in vitro diagnostics sector experienced a slight increase of 0.24% on July 4, with a net outflow of funds amounting to 42.33 million [1] Group 1: Market Performance - A total of 18 stocks in the sector saw gains, while 49 stocks declined [1] - The top decliners included Dongfang Ocean (-6.51%), Xilong Scientific (-3.81%), and Nearshore Protein (-2.54%) [1][1] Group 2: Stock Performance - Notable gainers included: - Hotgen Biotech with a price of 194.81 and an increase of 20.08%, attracting a net fund inflow of 2.125 million [1] - Saily Medical at 21.08, up 10.02%, with a net inflow of 1.758 million [1] - Zhongyuan Union at 25.87, rising 9.99%, with a net inflow of 1.38 billion [1] - Decliners included: - Botao Biotech at 37.34, down 3.38%, with a net outflow of 1.087 million [1] - Maike Biotech at 7.99, down 2.44%, with a net inflow of 176.92 thousand [1]